Biovet to invest Rs. 200 cr to expand Karnataka plant.

Biovet will invest Rs. 200 crore as part of its expansion plans to meet the growing demand of vaccines, especially for the Foot and Mouth Disease (FMD) and Brucellosis.

It has started work on expanding the FMD vaccine manufacturing facility in Malur, Karnataka.

Biovet promoter Krishna Ella said: “Expansion of our FMD vaccine facilities to deliver 200 million doses is an important step to increase our contribution to meet the shortage of this vaccine in the country.”

The Bengaluru-based company will construct a new Brucella vaccine production facility at the Malur site to produce 100 million doses a year. It will make Biovet the world’s largest manufacturer of this vaccine, he said.

HBL